Department of Defense Exercises Options Under Contract for Nerve Agent Medical Countermeasure Program
11:13 EDT 9 Aug 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
ANNAPOLIS, Md., Aug. 9, 2012 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Department of Defense (DoD) has elected to exerc...
Other Sources for this Article
More From BioPortfolio on "Department of Defense Exercises Options Under Contract for Nerve Agent Medical Countermeasure Program"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
